Observational study of feasibility of efficacy and safety of new endoscopic treatment for early gastric cancers

Observational study of feasibility of efficacy and safety of new endoscopic treatment for early gastric cancers - Observational study of feasibility of efficacy and safety of new endoscopic treatment for early gastric cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036674

Enrollment

1033

Registered

2019-05-08

Start date

2019-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Early gastric cancers (T1a) 2. Performance status 0 and 2 3. Plt => 100,000/mm3 Creatinine <= 3.0 mg/dl AST <= 200 IU/L ALT <= 200 IU/L T-bil <= 2.0 mg/dl Hb => 8.0 g/dl 4. Patients who gave written informed consent before entry in this study

Exclusion criteria

Exclusion criteria: 1. Ischemic heart disease 2. Liver cirrhosis, active hepatitis 3. Interstitial pneumonia 4. Haemodialysis 5. Both malignant disorder 6. Doctor's decision not to register to this regimen

Design outcomes

Primary

Measure	Time frame
Postoperative complication rates in endoscopic submucosal tunnel dissection	—

Secondary

Measure	Time frame
Surgical process (operative time, devices, general anesthesia operation transfer rate), postoperative course (oral intake, length of stay, inflammatory findings, the rates of late complications, stenosis), postoperative overall survival rate	—

Countries

Japan

Contacts

Public ContactToshiyasu Ojima

Wakayama Medical University School of Medicine Second Department of Surgery

tojima@wakayama-med.ac.jp073-441-0613

Outcome results